Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:50 PM
Ignite Modification Date:
2025-12-24 @ 11:50 PM
NCT ID:
NCT04945551
Eligibility Criteria:
Inclusion Criteria:
* Overweight to obese (BMI 28-35 kg/m2)
* Normal resting ECG
Specific for patients with T2D:
* In antiglycemic treatment with diet +/- metformin, SLGT-2 inhibitors, sulfonylurea, GLP1-RA, or DPPV-4 inhibitors
* Time since diagnosis max 4 yrs
Exclusion Criteria:
* Diagnosed with cardiovascular disease (minor to moderate hypertension allowed, defined as prescribed maximally two different antihypertensive drugs)
* Epilepsy
* Kidney disease (GFR\<50 ml/min)
* Regular exercise activity
* Inability to perform bicycling and rowing ergometer exercise
* Inability to understand Danish language (written and spoken)
Specific for patients with T2D:
\- Insulin treatment
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
40 Years
Maximum Age:
60 Years
Study:
NCT04945551
Study Brief:
Protocol Section:
NCT04945551